Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia - Dickinson, M., Cherif, H., Fenaux, P., Mittelman, M., Verma, A., Portella, M. S. O., Burgess, P., Ramos, P. M., Choi, J., Platzbecker, U., on behalf of the SUPPORT study investigators (American Society of Hematology (ASH), 2018)
6372734
Keywords: W; WW-YZ